Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.

作者: Tik-Shun Ho , Yuk-Ping Ho , Wing-Yin Wong , Lawrence Chi-Ming Chiu , Yum-Shing Wong

DOI: 10.1016/J.BIOPHA.2007.08.020

关键词: Poly ADP ribose polymeraseCell cultureCaspaseMolecular biologyApoptosisCeruleninCell cycleProgrammed cell deathBiologyPropidium iodide

摘要: Fatty acid synthase (FAS) has been shown previously to be highly expressed in breast and prostate carcinomas, but low expression level normal tissues. We also found this study that FAS was a number of cancer cell lines different histotypes. The growth-inhibitory effects inhibitors cerulenin C75 were then investigated on these lines, particularly the human melanoma A-375. MTT assay revealed proliferation viability reduced dose- time-dependently by 20.8%-87.1% control levels after 24 48 h treatment with 20-160 microM inhibitor. Immunoblotting studies showed both induced poly(ADP-ribose) polymerase (PARP) cleavage cells dose-dependently. Procaspase-3 processed into active smaller 17 19 kDa subunits, administration pan-caspase inhibitor Z-VAD-FMK completely rescued from PARP cleavage. This indicated cerulenin- C75-induced apoptosis involved caspase activation. proapoptotic further confirmed using confocal microscopy annexin-V FITC propidium iodide staining. DNA flow cytometric demonstrated accumulated G2/M preceding elevation sub G1 or apoptotic fragmented DNA. cycle arrest associated p21 depletion Bcl-xL Mcl-1, respectively. Results suggest retard growth A-375 cells, involving activation caspase-dependent apoptosis.

参考文章(37)
Koen Brusselmans, Ellen De Schrijver, Johannes V. Swinnen, Walter Heyns, Guido Verhoeven, RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Research. ,vol. 63, pp. 3799- 3804 ,(2003)
Ellen S. Pizer, Ji-Nong Li, Michele K. Evans, Myriam Gorospe, Francis J. Chrest, Wan Fang Han, Tirukalikundram S. Kumaravel, Pharmacological Inhibition of Fatty Acid Synthase Activity Produces Both Cytostatic and Cytotoxic Effects Modulated by p53 Cancer Research. ,vol. 61, pp. 1493- 1499 ,(2001)
Francis P. Kuhajda, Ellen S. Pizer, Henry S. Heine, Fawn D. Wood, Gary R. Pasternack, Fedor E. Romantsev, Inhibition of Fatty Acid Synthesis Delays Disease Progression in a Xenograft Model of Ovarian Cancer Cancer Research. ,vol. 56, pp. 1189- 1193 ,(1996)
P.E. Tyllianakis, S.E. Kakabakos, G.P. Evangelatos, D.S. Ithakissios, Direct Colorimetric Determination of Solid-Supported Functional Groups and Ligands Using Bicinchoninic Acid Analytical Biochemistry. ,vol. 219, pp. 335- 340 ,(1994) , 10.1006/ABIO.1994.1273
Uzma S Shah, Rajiv Dhir, Susanne M Gollin, Uma R Chandran, Dale Lewis, Marie Acquafondata, Beth R Pflug, None, Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Human Pathology. ,vol. 37, pp. 401- 409 ,(2006) , 10.1016/J.HUMPATH.2005.11.022
S J Heiligtag, R Bredehorst, K A David, Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death & Differentiation. ,vol. 9, pp. 1017- 1025 ,(2002) , 10.1038/SJ.CDD.4401055
Binqiu Liu, Yingqiang Wang, Kerry Fillgrove, Vernon Anderson, Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells Cancer Chemotherapy and Pharmacology. ,vol. 49, pp. 187- 193 ,(2002) , 10.1007/S00280-001-0399-X
Piero L. Alo, Paolo Visca, Adele Marci, Antonella Mangoni, Claudio Botti, Ugo Di Tondo, Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients Cancer. ,vol. 77, pp. 474- 482 ,(1996) , 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K